10.1158/0008-5472.CAN-07-6161 Cancer Res
ACE/ARB, angiotensin converting enzyme inhibitors/angiotensin-receptor blockers Postop, Postprocedural
We found that therapeutic doses decrease liver GSH by only modest amounts (10%), but that overdoses of 10 grams or more severely deplete liver GSH (Figure6)
GO analyses showed that genes associated with the 732 hyper-DMRs are highly enriched in metabolic pathways, such as RNA metabolism, fatty acid oxidation, and lipid oxidation
Are there any side effects
In a recent double-blind, randomized, placebo-controlled trial, the effect of ALCAR was examined in 229 participants treated for type 2 diabetes mellitus, hypertension, and dyslipidemia (46)